Your daily nutrition should include: High-Fiber Foods for GLP-1 Production: Vegetables : Artichokes, asparagus, Brussels sprouts, broccoli, and leafy greens (aim for 7-9 servings daily) Resistant Starch Sources : Cooked and cooled potatoes, green bananas, and legumes Prebiotic-Rich Foods : Onions, garlic, leeks, Jerusalem artichokes, and dandelion greens Whole Grains : Oats (especially for beta-glucan), quinoa, and barley Legumes : Lentils, chickpeas, and black beans (excellent for both fiber and protein) Healthy Fats for Satiety and GLP-1 Support: Olive oil, rich in oleic acid and 2-Oleoyl Glycerol (2-OG), has been shown to support natural GLP-1 production Extra virgin olive oil (use liberally in cooking and dressings) Avocados and avocado oil Nuts and seeds (especially walnuts, flaxseeds, and chia seeds) Fatty fish rich in omega-3s (wild salmon, sardines, mackerel) Fermented Foods for Microbiome Diversity: Foods like yogurt, kefir, kimchi, and sauerkraut support a balanced gut microbiome and regular consumption introduces beneficial bacteria that may naturally boost GLP-1 Kefir (dairy or coconut-based) Kimchi and sauerkraut Kombucha (unsweetened) Miso and tempeh Plain, full-fat yogurt with live cultures Protein Strategy for Muscle Preservation: Aim for 1.2-1.5 grams of protein per kilogram of body weight daily, distributed across meals: Lean proteins: Wild-caught fish, organic poultry, grass-fed beef Plant proteins: Legumes, quinoa, hemp seeds, spirulina Consider collagen peptides for additional support 2
Short-acting formulations reach peak plasma concentrations within 1-3.5 hours and have shorter elimination half-lives, while long-acting agents like semaglutide have half-lives of approximately one week, allowing for sustained therapeutic effects
I notice you use a broccoli seed extract in your formulation containing 40 mg SGS
The primary action of GLP-1 receptor agonists is to increase insulin production in response to high blood sugar levels
Carr, and Margreet C
10 Similarly, another systematic review and meta-analysis of 764 randomised controlled trials also showed a reduction in all-cause mortality with use of GLP-1RAs (odds ratio [OR] 0.88
